Open Access

Abnormal expression and mutation of the RBPJ gene may be involved in CD59‑ clonal proliferation in paroxysmal nocturnal hemoglobinuria

  • Authors:
    • Liyan Li
    • Hui Liu
    • Honglei Wang
    • Zhaoyun Liu
    • Yingying Chen
    • Lijuan Li
    • Jia Song
    • Guojin Wang
    • Rong Fu
  • View Affiliations

  • Published online on: April 10, 2019     https://doi.org/10.3892/etm.2019.7475
  • Pages: 4536-4546
  • Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired clonal proliferative disease of hematopoietic stem cells. Various gene mutations, including the phosphatidylinositol glycan anchor biosynthesis class A (PIG‑A) gene, may contribute to the proliferation of PNH clones. In order to explore the mechanism of PNH clone proliferation, a study was performed on 13 patients with PNH who underwent whole exome sequencing. The frequency of mutations in these patients was explored, and an additional 30 patients with PNH were selected for analysis of cluster of differentiation 59‑negative (CD59‑) cells. The mRNA expression of 13 genes, which were selected based on their high frequency in patients with PNH and the fact that they met four screening conditions, was determined in these CD59‑ cells. Cell proliferation, apoptosis and cell cycle were evaluated upon knocking down the recombinant signal binding protein of immunoglobulin κJ region (RBPJ) gene in 5 patients in vitro. The detection rate of PIG‑A gene mutation was 61.54% (8/13), and additional mutations in somatic genes were detected, including RBPJ, zinc finger protein 717, polycomb repressive complex 2 subunit and tet methylcytosine dioxygenase. Upon screening according to the mutation frequency and expression level, the present study focused on the RBPJ gene. The expression level of RBPJ in CD59‑ cells was apparently higher than that in CD59+ cells and normal controls which was significantly correlated with clinical data. Furthermore, the expression of RBPJ in PNH primary cells could be effectively inhibited by small interfering RNA‑RBPJ. Once the expression of RBPJ decreased remarkably, the apoptotic rate increased gradually, while cell proliferation activity decreased with transfection time and cells were blocked in G0/G1 phase. In conclusion, mutations and abnormal expression of the RBPJ gene may participate in the abnormal proliferation of PNH clones.

References

1 

Rotoli B and Luzzatto L: Paroxysmal nocturnal hemoglobinuria. Semin Hematol. 26:201–207. 1989.PubMed/NCBI

2 

Luzzatto L: Recent advances in the pathogenesis and treatment of paroxysmal nocturnal hemoglobinuria. F1000Res. 5:2092016. View Article : Google Scholar

3 

Parker CJ: The pathophysiology of paroxysmal nocturnal hemoglobinuria. Exp Hematol. 35:523–533. 2007. View Article : Google Scholar : PubMed/NCBI

4 

Hill A, DeZern AE, Kinoshita T and Brodsky RA: Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers. 3:170282017. View Article : Google Scholar : PubMed/NCBI

5 

Schrezenmeier H, Muus P, Socié G, Szer J, Urbano-Ispizua A, Maciejewski JP, Brodsky RA, Bessler M, Kanakura Y, Rosse W, et al: Baseline characteristics and disease burden in patients in the international Paroxysmal Nocturnal Hemoglobinuria registry. Haematologica. 99:922–929. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Socié G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, Heudier P, Rochant H, Cahn JY and Gluckman E: Paroxysmal nocturnal hemoglobinuria: Long-term follow-up and prognostic factors. Lancet. 348:573–577. 1996. View Article : Google Scholar : PubMed/NCBI

7 

de Latour RP, Mary JY, Salanoubat C, Terriou L, Etienne G, Mohty M, Roth S, de Guibert S, Maury S, Cahn JY, et al: Paroxysmal nocturnal hemoglobinuria: Natural history of disease subcategories. Blood. 112:3099–3106. 2008. View Article : Google Scholar : PubMed/NCBI

8 

Li LY, Liu ZY, Liu H, Liu CY, Shao ZH and Fu R: Deep Sequencing of whole genome exon inParoxysmal Nocturnal Hemoglobinuria. Am J Hematol. 92:E51–E53. 2017. View Article : Google Scholar : PubMed/NCBI

9 

Ramdzan ZM and Nepveu A: CUX1, a haploinsufficient tumour suppressor gene over-expressed in advanced cancers. Nat Rev Cancer. 14:673–682. 2014. View Article : Google Scholar : PubMed/NCBI

10 

Kridel R, Sehn LH and Gascoyne RD: Pathogenesis of follicular lymphoma. J Clin Invest. 122:3424–3431. 2012. View Article : Google Scholar : PubMed/NCBI

11 

Montagner S, Leoni C, Emming S, Della Chiara G, Balestrieri C, Barozzi I, Piccolo V, Togher S, Ko M, Rao A, et al: TET2 regulates mast cell differentiation and proliferation through catalytic and non-catalytic activities. Cell Rep. 15:1566–1579. 2016. View Article : Google Scholar : PubMed/NCBI

12 

Sugimori C, Padron E, Caceres G, Shain K, Sokol L, Zhang L, Tiu R, O'Keefe CL, Afable M, Clemente M, et al: Paroxysmal nocturnal hemoglobinuria and concurrent JAK2(V617F) mutation. Blood Cancer J. 2:e632012. View Article : Google Scholar : PubMed/NCBI

13 

Fraiman YS, Cuka N, Batista D, Vuica-Ross M and Moliterno AR: Development of paroxysmal nocturnal hemoglobinuria in CALR-positive myeloproliferative neoplasm. J Blood Med. 30:107–110. 2016.

14 

Chen Y, Tao S, Deng Y, Song L and Yu L: Chronic myeloid leukemia transformation in a patient with paroxysmal nocturnal hemoglobinuria: A rare case report with literature review. Int J Clin Exp Med. 15:8226–8229. 2015.

15 

Tominaga R, Katagiri T, Kataoka K, Kataoka K, Wee RK, Maeda A, Gomyo H, Mizuno I, Murayama T, Ogawa S and Nakao S: Paroxysmal nocturnal hemoglobinuria induced by the occurrence of BCR-ABL in a PIGA mutant hematopoietic progenitor cell. Leukemia. 30:1208–1210. 2016. View Article : Google Scholar : PubMed/NCBI

16 

Orent W, Mchenry AR, Rao DA, White C, Klein HU, Bassil R, Srivastava G, Replogle JM, Raj T, Frangieh M, et al: Rheumatoid arthritis-associated RBPJ polymorphism alters memory CD4+ T cells. Hum Mol Genet. 25:404–417. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Nagao H, Setoguchi T, Kitamoto S, Ishidou Y, Nagano S, Yokouchi M, Abematsu M, Kawabata N, Maeda S, Yonezawa S and Komiya S: RBPJ is a novel target for rhabdomyosar coma therapy. PLoS One. 7:e392682012. View Article : Google Scholar : PubMed/NCBI

18 

Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R, Hillmen P, Luzzatto L, Young N, Kinoshita T, et al: Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 106:3699–3709. 2006. View Article : Google Scholar

19 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

20 

Kalejta RF, Shenk T and Beavis AJ: Use of a membrane-localized green fluorescent protein allows simultaneous identification of transfected cells and cell cycle analysis by flow cytometry. Cytometry. 29:286–291. 1997. View Article : Google Scholar : PubMed/NCBI

21 

Shen W, Clemente MJ, Hosono N, Yoshida K, Przychodzen B, Yoshizato T, Shiraishi Y, Miyano S, Ogawa S, Maciejewski JP and Makishima H: Deep sequencing reveals stepwise mutation acquisition in paroxysmal nocturnal hemoglobinuria. J Clin Invest. 124:4529–4538. 2014. View Article : Google Scholar : PubMed/NCBI

22 

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al: Standards and guidelines for the interpretation of sequence variants: A joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 17:405–424. 2015. View Article : Google Scholar : PubMed/NCBI

23 

Karadimitris A and Luzzatto L: The cellular pathogenesis of paroxysmal noctural hemogolbinuria. Leukemia. 15:1148–1152. 2001. View Article : Google Scholar : PubMed/NCBI

24 

Dacie JV: Paroxysmal nocturnal haemoglobinuria. Proc R Soc Med. 56:587–596. 1963.PubMed/NCBI

25 

Brodsky RA, Vala MS, Barber JP, Medof ME and Jones RJ: Resistance to apoposis caused by PIG-A mutations in paroxysmal noctural hemogolbinuria. Proc Natl Acad Sci USA. 94:8756–8760. 1997. View Article : Google Scholar : PubMed/NCBI

26 

Horikawa K, Nakakuma H, Kawaguchi T, Iwamoto N, Nagakura S, Kagimoto T and Takatsuki K: Apoptosis resistance of blood cells from patients with paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome. Blood. 90:2716–2722. 1997.PubMed/NCBI

27 

Hansen NE and Killmann SA: Paroxysmal nocturnal hemoglobinuria in myelofibrosis. Blood. 36:428–431. 1970.PubMed/NCBI

28 

Luzzatto L, Familusi JB, Williams CK, Junaid TA, Rotoli B and Alfinito F: The PNH abnormality in myeloproliferative disorders: Association of PNH and acute erythremic myelosis in two children. Haematologica. 64:13–30. 1979.PubMed/NCBI

29 

Nishimura JI, Inoue N, Azenishi Y, Hirota T, Akaogi T, Shibano M, Kawagoe K, Ueda E, Machii T and Takeda J: Analysis of PIG-A gene in a patient who developed reciprocal translocation of chromosome 12 and paroxysmal nocturnal hemoglobinuria during follow-up of aplastic anemia. Am J Hematol. 51:229–233. 1996. View Article : Google Scholar : PubMed/NCBI

30 

Inoue N, Izui-Sarumaru T, Murakami Y, Endo Y, Nishimura J, Kurokawa K, Kuwayama M, Shime H, Machii T, Kanakura Y, et al: Molecular basis of clonal expansion of hematopoiesis in 2 patients with Paroxysmal nocturnal hemoglobinuria. Blood. 108:4232–4236. 2006. View Article : Google Scholar : PubMed/NCBI

31 

Brodsky RA: Paroxysmal nocturnal hemoglobinuria: Stem cells and clonality. Hematology Am Soc Hematol Educ Program. 111–115. 2008. View Article : Google Scholar : PubMed/NCBI

32 

Katagiri T, Tominaga R, Kataoka K, Maeda A, Gomyo H, Mizuno I, Murayama T, Ogawa S and Nakao S: A cure for paroxysmal nocturnal hemoglobinuria using molecular targeted therapy specific to a driver mutation. Blood. 126:12152015.

33 

Cancer Genome Atlas Research Network, ; Ley TJ, Miller C, Ding L, Raphael BJ, Mungall AJ, Robertson A, Hoadley K, Triche TJ Jr, Laird PW, et al: Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 368:2059–2074. 2013. View Article : Google Scholar : PubMed/NCBI

34 

Leproust E: Target-enrichment strategies for next generation sequencing. MLO Med Lab Obs. 44:26–27. 2012.PubMed/NCBI

35 

Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, Huff CD, Shannon PT, Jabs EW, Nickerson DA, et al: Exome sequencing identifies the cause of a mendelian disorder. Nat Genet. 42:30–35. 2010. View Article : Google Scholar : PubMed/NCBI

36 

Warr A, Robert C, Hume D, Archibald A, Deeb N and Watson M: Exome sequencing: Current and future perspectives. G3 (Bethesda). 5:1543–1550. 2015. View Article : Google Scholar : PubMed/NCBI

37 

Liu C, Shi X, Wang L, Wu Y, Jin F, Bai C and Song Y: SUZ12 is involved in progression of non-small cell lung cancer by promoting cell proliferation and metastasis. Tumour Biol. 35:6073–6082. 2014. View Article : Google Scholar : PubMed/NCBI

38 

Kulic I, Robertson G, Chang L, Baker JH, Lockwood WW, Mok W, Fuller M, Fournier M, Wong N, Chou V, et al: Loss of the Notch effector RBPJ promotes tumorigenesis. J Exp Med. 212:37–52. 2015. View Article : Google Scholar : PubMed/NCBI

39 

Wong CC, Martincorena I, Rust AG, Rashid M, Alifrangis C, Alexandrov LB, Tiffen JC, Kober C; Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium, ; Green AR, et al: Inactivating CUX1 mutations promote tumorigenesis. Nat Genet. 46:33–38. 2014. View Article : Google Scholar : PubMed/NCBI

40 

Wienand K and Shires K: The use of MAGE C1 and flow cytometry to determine the malignant cell type in multiple myeloma. PLoS One. 10:e01207342015. View Article : Google Scholar : PubMed/NCBI

41 

Mugnaini E and Floris A: The unipolar brush cell: A neglected neuron of the mammalian cerebellar cortex. J Comp Neurol. 339:174–180. 1994. View Article : Google Scholar : PubMed/NCBI

42 

Nunzi MG, Birnstiel S, Bhattacharyya BJ, Slater NT and Mugnaini E: Unipolar brush cells from a glutamatergic projection system within the mouse cerebellar cortex. J Comp Neurol. 434:329–341. 2001. View Article : Google Scholar : PubMed/NCBI

43 

Sotelo C and Changeux JP: Bergmann fibers and granular cell migration in the cerebellum of homozygous weaver mutant mouse. Brain Res. 77:484–491. 1974. View Article : Google Scholar : PubMed/NCBI

44 

Gerhardt DM, Pajcini KV, D'altri T, Tu L, Jain R, Xu L, Chen MJ, Rentschler S, Shestova O, Wertheim GB, et al: The Notch1 transcriptional activation domain is required for development and reveals a novel role for Notch1 signaling in fetal hematopoietic stem cells. Gene Dev. 28:576–593. 2014. View Article : Google Scholar : PubMed/NCBI

45 

Maillard I, Weng AP, Carpenter AC, Rodriguez CG, Sai H, Xu L, Allman D, Aster JC and Pear WS: Mastermind critically regulates Notch-mediated lymphoid cell fate decisions. Blood. 104:1696–1702. 2004. View Article : Google Scholar : PubMed/NCBI

46 

Lv Q, Shen R and Wang J: RBPJ inhibition impairs the growth of lung cancer. Tumour Biol. 36:3751–3756. 2015. View Article : Google Scholar : PubMed/NCBI

47 

Xue L, Li H, Chen Q, Wang Z, Zhang P, Chen H, Wang Z and Chong T: Inhibition of recombining binding protein suppressor of hairless (RBPJ) Impairs the growth of prostate cancer. Cell Physiol Biochem. 36:1982–1990. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

June 2019
Volume 17 Issue 6

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Li, L., Liu, H., Wang, H., Liu, Z., Chen, Y., Li, L. ... Fu, R. (2019). Abnormal expression and mutation of the RBPJ gene may be involved in CD59‑ clonal proliferation in paroxysmal nocturnal hemoglobinuria. Experimental and Therapeutic Medicine, 17, 4536-4546. https://doi.org/10.3892/etm.2019.7475
MLA
Li, L., Liu, H., Wang, H., Liu, Z., Chen, Y., Li, L., Song, J., Wang, G., Fu, R."Abnormal expression and mutation of the RBPJ gene may be involved in CD59‑ clonal proliferation in paroxysmal nocturnal hemoglobinuria". Experimental and Therapeutic Medicine 17.6 (2019): 4536-4546.
Chicago
Li, L., Liu, H., Wang, H., Liu, Z., Chen, Y., Li, L., Song, J., Wang, G., Fu, R."Abnormal expression and mutation of the RBPJ gene may be involved in CD59‑ clonal proliferation in paroxysmal nocturnal hemoglobinuria". Experimental and Therapeutic Medicine 17, no. 6 (2019): 4536-4546. https://doi.org/10.3892/etm.2019.7475